文献速递肿瘤 PET/CT

冷混合策略增强放疗后[18F]-C-SNAT4 PET凋亡显像

Augmentation of [18F]-C-SNAT4 PET imaging of apoptosis after radiotherapy using a cold mixing strategy.
PubMed 文献 · EJNMMI Res · 2025-06-03

研究在体外NCI-H460细胞和小鼠异种移植模型中比较热[18F]-C-SNAT4与热/冷混合[18F]/[19F]-C-SNAT4对放疗诱导凋亡的显像效果。1:80热/冷混合物体外使信号较[18F]-C-SNAT4单独提高1.6倍;高剂量放疗体内信号提高2.5倍,低剂量放疗凋亡仅热/冷混合物检出、信号为热[18F]-C-SNAT4的2.4倍。结论为热/冷混合物信号显著更高、检测治疗反应灵敏度更高,可能为凋亡特异性放射性核素临床转化中灵敏度低的问题提供解决方案。

要点

  • 1:80热/冷混合物体外较[18F]-C-SNAT4单独使信号提高1.6倍。
  • 高剂量放疗小鼠NCI-H460异种移植模型中热/冷混合物信号提高2.5倍。
  • 低剂量放疗诱导凋亡仅热/冷混合物检出,信号为热[18F]-C-SNAT4的2.4倍。

核心结论

  • 热/冷混合[18F]/[19F]-C-SNAT4较热[18F]-C-SNAT4产生显著更多信号,检测治疗反应灵敏度更高;这可能为凋亡特异性放射性核素临床转化中灵敏度低的问题提供解决方案。

研究设计与样本

  • 体外使用人非小细胞肺癌NCI-H460细胞检测放疗诱导凋亡,比较热[18F]-C-SNAT4与热/冷混合[18F]/[19F]-C-SNAT4的摄取。
  • 体内在小鼠异种移植模型中设高剂量放疗组与低剂量放疗组,比较热[18F]-C-SNAT4与热/冷混合物的信号。
  • 在250倍和10倍各自剂量下评估毒性与剂量学安全性,并归一化为人等效剂量。

主要发现

  • 体外热[18F]-C-SNAT4与热/冷混合[18F]/[19F]-C-SNAT4在放疗处理较未处理NCI-H460细胞中摄取均显著增加。
  • 体外1:80热/冷混合物较[18F]-C-SNAT4单独使信号提高1.6倍。
  • 高剂量放疗小鼠NCI-H460异种移植模型中热/冷混合物信号提高2.5倍。
  • 低剂量放疗诱导的凋亡仅热/冷混合物检出,信号为热[18F]-C-SNAT4的2.4倍。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Positron Emission Tomography (PET) imaging can monitor cancer treatment response by non-invasively detecting apoptosis in vivo. Signal-to-noise (SNR) remains one of the critical barriers to approval for clinical use. We have previously developed a PET tracer [18 F]-C-SNAT4 for imaging capase-3 activity in apoptotic tumors induced by chemo- and immunotherapy. [18 F]-C-SNAT4 is designed to undergo caspase-3 activated intramolecular cyclization. The product then self-assembles in situ into nanoparticles to generate preferential retention of F18 radioactivity in apoptotic cells. This unique mechanism prompted us to investigate if a cold mixture could enhance the probe retention and further augment the sensitivity for imaging radiotherapy. RESULTS: [18 F]-C-SNAT4 and hot/cold mixture [18 F]/[19 F]-C-SNAT4 were used to detect human NSCLC (NCI-H460) apoptosis induced by radiation. Both hot [18 F]-C-SNAT4 and hot/cold mixture [18 F]/[19 F]-C-SNAT4 had significantly increased uptake in radiation treated vs. untreated NCI-H460 cells in vitro. A 1: 80 hot/cold mixture increased signal by 1.6x compared to [18 F]-C-SNAT4 alone. In vivo studies were performed in murine xenograft models in high-dose radiation and low-dose radiation treatment groups. The hot/cold mixture showed an increase in the signal by 2.5x in high-dose radiation treated murine NCI-H460 xenograft models. Low-dose radiation induced apoptosis was only detected with the hot/cold mixture with 2.4x signal compared to hot [18 F]-C-SNAT4. Toxicity and dosimetry safety were evaluated at 250x and 10x respective dosages, then normalized to human dose equivalent. CONCLUSION: A hot/cold mixture of [18 F]/[19 F]-C-SNAT4 generates significantly more signal compared to hot [18 F]-C-SNAT4, leading to higher sensitivity in detecting treatment response. This may present a solution to low sensitivity in the translation of apoptosis-specific radionuclides to clinical application.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Qiu J, Chen M, Chen Z, et al. Augmentation of [18F]-C-SNAT4 PET imaging of apoptosis after radiotherapy using a cold mixing strategy. EJNMMI Res. 2025. PMID: 40459707. doi:10.1186/s13550-025-01255-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。